Company intelligence / Profile preview

Hzymes Biotechnology

Wuhan, Hubei Province, Chinahzymesbiotech.com ↗

Ownership: Private
Development stage: Commercial

Overview

Hzymes Biotechnology is a leading Chinese biotech specializing in the R&D and large-scale production of enzymes, recombinant proteins, antibodies, antigens, plasmids, and other raw materials for the biopharmaceutical and in vitro diagnostics (IVD) sectors. It offers comprehensive CDMO/CRO services including custom enzyme development for mRNA therapeutics/vaccines production as well as molecular diagnostic solutions. Its products are used globally by over 100 companies across more than 25 countries.

Modalities: Recombinant proteinEnzymeAntibodymRNA-based drugsPlasmid DNA
Industry: Contract Manufacturing Organization

Partnerships

Over 100 domestic and international IVD reagent manufacturerspartnerships with global clients in pharma/diagnostics sectors

Beyond the preview

Go deeper on Hzymes Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hzymes Biotechnology.

Explore the full profile